Changes in chemiluminescence of whole blood of COPD patients treated with hypoxen® and effects of C60 fullerenes on blood chemiluminescence

Medical Science Monitor

Volumn 18, Issue 2, 2012, Pages

  Novikov, Kirill N ^a   Berdnikova, Nadezhda G ^b   Novikov, Alexey K ^b   Lyusina, Oksana Y ^a   Muhitova, Olga G ^a   Yablonskaya, Olga I ^a   Minh, Ha Do ^a   Voeikov, Vladimir L ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Blood; Chemiluminescence; Chronic obstructive pulmonary disease; Fullerenes; Hypoxen; Reactive oxygen species

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FULLERENE DERIVATIVE; HYDRATED FULLERENE C60; HYPOXEN; LUCIGENIN; LUMINOL; POLYDIHYDROXYPHENYLENTHIOSULFONATE SODIUM; REACTIVE OXYGEN METABOLITE; RESPIRATORY TRACT AGENT; UNCLASSIFIED DRUG; ZYMOSAN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LIGHT SCATTERING; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; REMISSION;

EID: 84857019736     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882460     Document Type: Article

References (21)

1. MacNee W, Tuder RM: 2 New paradigms in the pathogenesis of phron-ic pbstructive pulmonary pisease. Proc Am Thorac Soc, 2009; 6: 527-31
2. The Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2007
3. Skyba P, Kluchova Z, Joppa P et al: Nutritional status in relation to respiratory impairment and systemic infammation in patients with acute exacerbations of COPD. Med Sci Monit, 2009; 15(10): CR528-CR33
4. Pietras T, Szemraj J, Witusik A et al.: The sequence polymorphism of MnSOD gene in infjects with respiratory insuffciency in COPD. Med Sci Monit, 2010; 16(9): CR427-32
5. Cavalcante AGM, de Bruin PFC: The role of oxidative stress in COPD: current concepts and perspectives. J Bras Pneumol, 2009; 35: 1227-37
6. Bolevich SB: Bronchial asthma and free-radical processes. Moscow: Medicine, 2006 (in Russian)
7. Duke VA: Construction of psychodiagnostic tests: traditionalmathemat-ical models and algorithms. S.-P., 1994 (in Russian)
8. Voeikov VL. Reactive oxygen species (ROS): pathogens or sources of vital energy? Part 1. ROS in normal and pathologic physiology of living systems. J Alternat Complem Med, 2006; 12: 111-18
9. Voeikov VL, Asfaramov R, Bouravleva EV et al: Biophoton research in blood reveals its holistic properties. Indian J Exp Biol, 2003; 43: 473-82
10. Voeikov VL, Novikov CN, Siuch NI: Alterations in Luminol-enhanced CL from nondiluted whole blood in the course of low-level laser therapy of angina pectoris patients. In: Cohn, G.E, Soper, S.A., eds. Ultrasensitive Biochemical Diagnostics II, SPIE Proc 1997, San Jose, CA, USA 2985: 286-94
11. Andrievsky GV, Kosevich MV, Vovk OM et al: On the production of an aqueous colloidal solution of fullerenes. J Chem Soc Chem Commun, 1995; 12: 1281-82
12. Kroto HW, Heath JR, O'Brien SC et al: C60: Buckminsterfullerene. Nature, 1985; 318: 162-63
13. Fowler PW, Manolopoulos DE: An Atlas of Fullerenes. Oxford: Clarendon Press, 1995
14. Andrievsky GV, Kosevich MV, Vovk OM et al: On the production of an aqueous colloidal solution of fullerenes. J Chem Soc Chem Commun, 1995; 12: 1281-82
15. Andrievsky GV, Kondakov IK, Vovk OM: Comparative analysis of two aqueous-colloidal solutions of C60 fullerene with help of FT-IR refec-tance and UV-VIS spectroscopy. Chem Phys Letters, 2002; 364: 8-17
16. Andrievsky GV, Bruskov VI, Tykhomyrov AA, Gudkov SV: Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Rad Biol Med, 2009; 47: 786-93
17. Andrievsky GV, Burenin IS: On medicinal and preventive effcacy of small doses of hydrated C60 fullerenes at cancer pathologies. Chemistry Preprint Archive, 2002; 6: 53-68
18. Tykhomyrov AA, Nedzvetsky VS, Klochkov VK, Andrievsky GV: Nanostructures of hydrated C60 fullerene (C60HyFnC60) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals. Toxicology, 2008; 1-8
19. Andrievsky GV, Klochkov VK, Derevyanchenko LI: Is C60 fullerene molecular toxic?! Fullerenes, Nanotubes and Carbon Nanostructures, 2005; 13: 363-76
20. Andrievsky G, Shakhnin A, Tronza A, Zhernosekov D, Tykhomyrov A: The acceleration of blood plasma clot lysis in the presence of hydrated C60 fullerene nanostructures in super-small concentration. Fullerenes, Nanotubes and Carbon Nanostructures, 2010; 18: 303-11
21. Pal'mina NP, Mal'tseva EL, Kurnakova NV, Burlakova EB: The effect of alpha-tocopherol over a wide range of concentrations (10(-2)-10(-17) M) on protein kinase C activity. Connection with proliferation and tumor growth. Biochimika (Russian), 1994; 59: 193-200